The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
暂无分享,去创建一个
Francesco Bandello | Christian Simader | Paul Mitchell | Ursula Schmidt-Erfurth | Gabriela Burian | Andreas Weichselberger | Pascale Massin | P. Mitchell | U. Schmidt-Erfurth | P. Massin | C. Simader | F. Bandello | F. Sutter | G. Lang | R. Schlingemann | Gabriele E Lang | Reinier O Schlingemann | Florian Sutter | Ortrud Gerstner | A. Weichselberger | G. Burian | O. Gerstner
[1] Judy E. Kim,et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. , 2009, Archives of ophthalmology.
[2] T. Batchelder,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1995, Archives of ophthalmology.
[3] P. Ferreira,et al. How consistent are health utility values? , 2008, Quality of Life Research.
[4] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[5] P. Mitchell,et al. Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study. , 2004, Investigative ophthalmology & visual science.
[6] N. Bressler,et al. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. , 2009, Investigative ophthalmology & visual science.
[7] Elham Hatef,et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. , 2010, Ophthalmology.
[8] Gerald Liew,et al. Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.
[9] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[10] P Edwards. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010 .
[11] R. Gariano,et al. Diabetic retinopathy: a growing concern in an aging population. , 2009, Geriatrics.
[12] R. Klein,et al. Ten-year incidence of visual loss in a diabetic population. , 1994, Ophthalmology.
[13] L. Smeeth,et al. Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population? , 2006, BMC ophthalmology.
[14] Karen Bandeen-Roche,et al. How does visual impairment affect performance on tasks of everyday life? The SEE Project , 2002 .
[15] Lloyd Paul Aiello. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.
[16] Simon P. Harding,et al. Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study) , 2010, Diabetes Care.